The Global Thawing System Market is expected to reach USD 252.7 million, at a CAGR of 12.6%.
Factors driving the growth of this market include technologically advanced applications of thawing devices, expanding storage capacities of biorepositories, and increasing the use of thawed cells in the treatment of cancers and diabetes.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=185341188
Thawing System Market segmentation:
· based on the type
· based on sample type
· based on the end user
· based on regions
The Major Players Operating in the Thawing System Market:
Key players in the thawing system market include Helmer Scientific (US), Boekel Scientific (US), Sarstedt (Germany), Barkey (Germany), BioCision (US), Cardinal Health (US), Sartorius (Germany), GE Healthcare (US), Thermo Fisher Scientific (US), and CytoTherm (US).
The objectives of this study are as follows:
To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and research and development activities in the thawing system market
Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=185341188
Thawing System Market by End User:
- Blood Banks & Transfusion Centers
- Hospitals & Diagnostic Laboratories
- Cord Blood & Stem Cell Banks
- Research & Academic Institutes
- Biotechnology & Pharmaceutical Companies
- Tissue Banks
Geographical Detailed Analysis for Thawing System Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is estimated to dominate the thawing system market. This is attributed to factors such as improvements in blood bank and biobank infrastructure, increasing research activities in regenerative medicine as well as cell and gene therapy, growing interest in personalized medicine and biomarker discovery, increasing number of biotechnology and pharmaceutical companies, and increasing government funding.
